XML 86 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED INCENTIVE PLANS (Details) (USD $)
1 Months Ended 12 Months Ended
Jul. 31, 2013
Jul. 31, 2012
Jul. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award            
Aggregate number of shares authorized for issuance       66,000,000    
Cumulative shares issued during the period       16,000,000    
Maximum shares available for future issuance       20,000,000    
Number of shares counted for each share covered by an award in determining the number of shares that are available for future awards       3    
Number of times, as applicable, shares available for future awards may increase by shares that fail to vest, or are forfeited or canceled, or correspond to the portion of any stock-based awards settled in cash       3    
Restricted stock granted to non-employee directors       37,100    
Certain stock-based incentive amounts            
Compensation expense (in dollars)       $ 152,000,000 $ 78,000,000 $ 110,000,000
Income tax benefit recognized in the income statement (in dollars)       55,000,000 29,000,000 40,000,000
Intrinsic value of options and stock-settled SARs exercised (in dollars)       24,000,000 18,000,000 21,000,000
Cash paid       96,000,000 83,000,000 124,000,000
Fair value of RSUs and TSRIs vested during the year       83,000,000 28,000,000 53,000,000
Unrecognized compensation expense       205,000,000    
Weighted-average period over which unrecognized compensation expense is expected to be recognized       2 years    
RSUs
           
Stock-Based Awards            
Number of anniversaries for performance objectives to be satisfied       7    
Award vesting period       2 years    
RSUs | Minimum
           
Stock-Based Awards            
Award vesting period       2 years 2 years 2 years
RSUs | Maximum
           
Stock-Based Awards            
Award vesting period       3 years 3 years 3 years
Cliff vested RSU's | Minimum
           
Certain stock-based incentive amounts            
Weighted-average period over which unrecognized compensation expense is expected to be recognized       2 years 2 years 2 years
Cliff vested RSU's | Maximum
           
Certain stock-based incentive amounts            
Weighted-average period over which unrecognized compensation expense is expected to be recognized       3 years 3 years 3 years
Cash-Settled RSUs
           
Roll-forward of stock awards other than options and SARS.            
Unvested, beginning of period (in shares)       1,332,000    
Granted (in shares)       785,000    
Vested (in shares)       (613,000)    
Forfeitures (in shares)       (73,000)    
Unvested, end of period (in shares)       1,431,000 1,332,000  
Stock awards other than options and SARs, weighted-average grant-date fair value (in dollars per share)            
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share)       $ 90.27    
Granted, weighted-average grant-date fair value (in dollars per share)       $ 89.70 $ 84.38 $ 104.74
Vested, weighted-average grant-date fair value (in dollars per share)       $ 89.89    
Forfeitures, weighted-average grant-date fair value (in dollars per share)       $ 90.26    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share)       $ 90.12 $ 90.27  
Stock-Settled RSUs
           
Roll-forward of stock awards other than options and SARS.            
Unvested, beginning of period (in shares)       1,375,000    
Granted (in shares)       793,000    
Vested (in shares)       (438,000)    
Forfeitures (in shares)       (123,000)    
Unvested, end of period (in shares)       1,607,000 1,375,000  
Stock awards other than options and SARs, weighted-average grant-date fair value (in dollars per share)            
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share)       $ 88.23    
Granted, weighted-average grant-date fair value (in dollars per share)       $ 90.35 $ 84.81 $ 102.97
Vested, weighted-average grant-date fair value (in dollars per share)       $ 84.51    
Forfeitures, weighted-average grant-date fair value (in dollars per share)       $ 88.59    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share)       $ 90.26 $ 88.23  
Cash-settled SARs
           
Option and SAR transactions            
Beginning balance (in shares)       494,000    
Exercised (in shares)       (142,000)    
Ending balance (in shares)       352,000    
Exercisable, end of period (in shares)       352,000    
Option and SAR transactions            
Beginning balance, weighted average exercise price (in dollars per share)       $ 24.66    
Exercised, weighted average exercise price (in dollars per share)       $ 24.66    
Ending balance, weighted average exercise price (in dollars per share)       $ 24.66    
Exercisable, end of period, weighted average exercise price (in dollars per share)       $ 24.66    
Ending balance, weighted average remaining contractual term       6 months    
Exercisable, end of period, weighted average remaining contractual term       6 months    
Ending balance, aggregate intrinsic value (in dollars)       24,783,000    
Exercisable, end of period, aggregate intrinsic value (in dollars)       24,783,000    
TSRIs
           
Stock-Based Awards            
Award vesting period       3 years    
Roll-forward of stock awards other than options and SARS.            
Unvested, beginning of period (in shares)       1,930,000    
Granted (in shares)       135,000    
Vested (in shares)       (1,143,000)    
Forfeitures (in shares)       (90,000)    
Unvested, end of period (in shares)       832,000 1,930,000  
Stock awards other than options and SARs, weighted-average grant-date fair value (in dollars per share)            
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share)       $ 80.39    
Granted, weighted-average grant-date fair value (in dollars per share)       $ 91.97 $ 84.57 $ 102.97
Vested, weighted-average grant-date fair value (in dollars per share)       $ 72.44    
Forfeitures, weighted-average grant-date fair value (in dollars per share)       $ 87.05    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share)       $ 92.49 $ 80.39  
Grant-date assumptions used in the Monte Carlo simulation models            
Risk-free interest rate (as a percent)       0.60% 0.40% 0.60%
Dividend yield (as a percent)       2.80% 2.60% 1.80%
Volatility factor (as a percent)       30.00% 34.00% 33.00%
Expected life       3 years 3 years 3 years
Other disclosures            
Performance-based awards settled in stock (as a percent) 100.00% 100.00% 50.00%      
Performance-based awards settled for cash (as a percent)     50.00%      
TSRIs | Minimum
           
Other disclosures            
Payouts for Performance-based awards granted (as a percent) 0.00% 0.00% 0.00%      
TSRIs | Maximum
           
Other disclosures            
Payouts for Performance-based awards granted (as a percent) 150.00% 100.00% 100.00%      
Stock-settled SARs and Options
           
Stock-Based Awards            
Award vesting period       3 years    
Option and SAR transactions            
Beginning balance (in shares)       537,000    
Exercised (in shares)       (391,000)    
Forfeitures (in shares)       (1,000)    
Ending balance (in shares)       145,000    
Exercisable, end of period (in shares)       145,000    
Option and SAR transactions            
Beginning balance, weighted average exercise price (in dollars per share)       $ 31.88    
Exercised, weighted average exercise price (in dollars per share)       $ 28.12    
Forfeitures, weighted average exercise price (in dollars per share)       $ 15.57    
Ending balance, weighted average exercise price (in dollars per share)       $ 42.11    
Exercisable, end of period, weighted average exercise price (in dollars per share)       $ 42.11    
Ending balance, weighted average remaining contractual term       1 year 10 months 24 days    
Exercisable, end of period, weighted average remaining contractual term       1 year 10 months 24 days    
Ending balance, aggregate intrinsic value (in dollars)       7,701,000    
Exercisable, end of period, aggregate intrinsic value (in dollars)       $ 7,701,000    
Options and SARs | Minimum
           
Stock-Based Awards            
Term of award         3 years  
Options and SARs | Maximum
           
Stock-Based Awards            
Term of award         10 years  
Other awards granted in 2013
           
Stock-Based Awards            
Award vesting period       3 years    
Roll-forward of stock awards other than options and SARS.            
Granted (in shares)       160,000    
Stock awards other than options and SARs, weighted-average grant-date fair value (in dollars per share)            
Granted, weighted-average grant-date fair value (in dollars per share)       $ 80.98    
Other disclosures            
Performance-based awards settled in stock (as a percent)       100.00%    
Other awards granted in 2013 | Minimum
           
Other disclosures            
Payouts for Performance-based awards granted (as a percent)       0.00%    
Other awards granted in 2013 | Maximum
           
Other disclosures            
Payouts for Performance-based awards granted (as a percent)       200.00%